Federal Contractor Profile
Spero Therapeutics, INC.
Federal contracting record: $60M obligated across 3 awards from 1 agencies, FY 2018–2026.
Company Profile
Parent UEI (Unique Entity Identifier)
NX34PL7NZW24
CAGE Code
7SK81
Address
675 MASSACHUSETTS AVE 14TH FLR, CAMBRIDGE, MA, 021393309
First Federal Award
Dec 22, 2017
Most Recent Award
Jul 20, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- Department of Health and Human Services$60M
100.0% of total obligations
Top NAICS Activity
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Jun 17, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | IGF::OT::IGF | $6.4M |
| Aug 23, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541715 | TO ADVANCE CLINICAL AND NON-CLINICAL DEVELOPMENT OF AN ANTIBIOTIC CANDIDATE. | $3.4M |
| Jul 3, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | IGF::OT::IGF | $12M |
| Dec 20, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | IGF::OT::IGF | $642K |
| Aug 23, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541715 | TO ADVANCE CLINICAL AND NON-CLINICAL DEVELOPMENT OF AN ANTIBIOTIC CANDIDATE. | $85K |
| Aug 8, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541715 | TO ADVANCE CLINICAL AND NON-CLINICAL DEVELOPMENT OF AN ANTIBIOTIC CANDIDATE. | $780K |
| Dec 14, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541715 | TO ADVANCE CLINICAL AND NON-CLINICAL DEVELOPMENT OF AN ANTIBIOTIC CANDIDATE. | $149K |
| Oct 26, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541715 | TO ADVANCE CLINICAL AND NON-CLINICAL DEVELOPMENT OF AN ANTIBIOTIC CANDIDATE. | $4.0M |
| Sep 28, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | IGF::OT::IGF | $12M |
| Jan 14, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | IGF::OT::IGF | $13M |
| May 12, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541715 | TO ADVANCE CLINICAL AND NON-CLINICAL DEVELOPMENT OF AN ANTIBIOTIC CANDIDATE. | $2.1M |
| Sep 12, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541712 | IGF::OT::IGF - "DEVELOPMENT OF A SECOND GENERATION POLYMYXIN FOR THERAPY OF MDR GRAM-NEGATIVE INFECTIONS" | $211K |
| May 19, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | IGF::OT::IGF | $2.5M |
| Aug 3, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541712 | IGF::OT::IGF - "DEVELOPMENT OF A SECOND GENERATION POLYMYXIN FOR THERAPY OF MDR GRAM-NEGATIVE INFECTIONS" | $296K |
| Jul 12, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | IGF::OT::IGF | $16M |
| Apr 4, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541712 | IGF::OT::IGF - "DEVELOPMENT OF A SECOND GENERATION POLYMYXIN FOR THERAPY OF MDR GRAM-NEGATIVE INFECTIONS" | $275K |
Want to win work like Spero Therapeutics, INC.?
Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.